Investorideas.com Newswire

Investorideas.com Newswire
Be one of the most talked about companies (stocks) on social media

Investorideas.com newswire, biotech stocks and industry

Friday, May 27, 2016

Stock Directory Additions in Technology, Biotech, Gaming, Energy, Cleantech and Marijuana Stocks

Stock Directory Additions in Technology, Biotech, Gaming, Energy, Cleantech and Marijuana Stocks

Biotech Stocks Added Include: NYSE: XON; Nasdaq: BSTG, SBPH; OTC: EMBT, MRLA, EWLL, IGAP, MICBE, TLTFF; TSX: NRI; TSXV: TLT and Korea Stock Exchange 011000

Point Roberts, WA, Delta BC – May 26, 2016 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its global stock directories.  Additions include technology stocks, biotech/life sciences stocks, energy stocks, a medical marijuana stock, an online gaming/gambling stock and a new energy efficiency stock, Tecogen Inc. (NasdaqCM:TGEN), which designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products and is known for cost efficient, environmentally friendly and reliable products for energy production.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.


Companies added to Biotech/Life Sciences Stocks include: Biostage Inc. (NasdaqCM:BSTG), Ember Therapeutics, Inc (OTC:EMBT), Emerald Medical Applications Corp. (OTC:MRLA), eWellness Healthcare Corporation (OTC:EWLL), Integrity Applications, Inc. (OTC:IGAP), Microlin Bio, Inc. (OTC:MICBE), Nuvo Pharmaceuticals Inc. (TSX:NRI.TO), Spring Bank Pharmaceuticals Inc. (NasdaqCM:SBPH), Theralase Technologies Inc. (OTC:TLTFF; TSX:TLT.V), GeneOne Life Science Inc. (KSE:011000.KS; KRX:011000.KR), Intrexon Corporation (NYSE:XON)

Tech Companies Added: PeerLogix Inc. (OTC:LOGX), AgJunction Inc. (TSX:AJX.TO), CriticalControl Solutions Corp (TSX:CCZ.TO), BSM Technologies Inc. (TSX:GPS.V), Iridium Communications Inc. (NasdaqGS:IRDM), TomTom (Amsterdam: TOM2.AS; OTC:TMOAF), Espial Group Inc (TSX:ESP.TO), Halogen Software Inc (TSX:HGN.TO), Information Services Corp (TSX:ISV.TO), Kinaxis Inc (TSX:KXS.TO), Mediagrif Interactive Technologies Inc (TSX:MDF.TO), Perk.com Inc. (TSX:PER.TO), CGI Group Inc. (NYSE:GIB; TSX:GIB-A.TO), Calian Group Ltd (TSX:CGY.TO), D+H Corporation (TSX:DH.TO), Intermap Technologies Corp (TSX:IMP.TO), International Road Dynamics Inc (TSX:IRD.TO)

Other Sector Additions:
Energy Stocks: Pyxis Tankers Inc (NasdaqCM:PXS), International Western Petroleum, Inc. (OTC:INWP), NXT Energy Solutions Inc (TSX:SFD.TO)

Renewable Energy Stocks/Environment Stocks:
Tecogen Inc. (NasdaqCM:TGEN) designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including natural gas engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company is known for cost efficient, environmentally friendly and reliable products for energy production that, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 20 years, Tecogen has shipped more than 2,300 units, supported by an established network of engineering, sales, and service personnel across the United States.

Gaming Stocks:
Intertain Group Ltd, The (TSX:IT.TO; OTC:ITTNF) is an online gaming holding company that, through its operating subsidiaries, provides entertainment to global consumer base in which such subsidiaries operate. Intertain currently offers bingo-led gaming and casino to its customers using the InterCasino, Costa, Vera&John, Jackpotjoy and Botemania brands.

Marijuana/Hemp Stocks:
Notis Global, Inc (OTC:NGBL) Based in Los Angeles, Notis Global is a pioneer in the burgeoning, multi-billion dollar legal hemp industry. The Company and its partners are working to grow confidence and generate revenues in the hemp industry. Through our key partnership with Folium Biosciences, one of the largest hemp operations in the U.S., Notis is a leading provider and distributor of cannabidiol (CBD).

About Investorideas.com - News that Inspires Big Ideas
Sectors we cover in include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also expanded our global coverage to include Latin American stocks, the Middle East, sports and entertainment.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411





Friday, May 13, 2016

Investorideas Updates Global #Stock Directories; Additions Include #Biotech and #Mining Stocks, #Agriculture Stock (Nasdaq: $CERE)

Investorideas Updates Global #Stock Directories; Additions Include #Biotech and #Mining Stocks, #Agriculture Stock (Nasdaq: $CERE)

Biotech Stocks Added-Nasdaq: $CAPN, $CLRB, $CTRV, $EYEG, $MTBC, $OASM, $PULM, $VKTX; OTC: $BRTX, $CWBR, $HEWA, $NTRP, $PENC, $PMCB; TSX: $COB_U.V and Stockholm: $OASM.ST




Point Roberts, WA, Delta BC – May 13, 2016 – Investorideas.com, a global news source and investor resource covering leading sectors announces this week’s additions to its global stock directories include biotechnology/life sciences , mining stocks and an agricultural- biotechnology company that develops and markets seeds and traits to produce crops for animal feed, sugar and other markets.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks ranging from microcap to NYSE and listed on any recognized global stock exchange, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.


Biotech Companies : BioRestorative Therapies, Inc. (OTC:BRTX), Capnia, Inc. (NasdaqCM:CAPN), Cellectar Biosciences, Inc. (NasdaqCM:CLRB), CohBar, Inc. (TSX:COB-U.V; OTC:CWBR), ContraVir Pharmaceuticals (NasdaqCM:CTRV), EyeGate Pharmaceuticals Inc. (NasdaqCM:EYEG), HealthWarehouse.com, Inc. (OTC:HEWA), Medical Transcription Billing Corp. (NasdaqCM:MTBC), Neurotrope Bioscience, Inc. (OTC:NTRP), Oasmia Pharmaceutical AB (NasdaqCM:OASM; Stockholm:OASM.ST), PEN Inc. (OTC:PENC), PharmaCyte Biotech, Inc. (OTC:PMCB), Pulmatrix (NasdaqGM:PULM), Viking Therapeutics (NasdaqCM:VKTX)

Companies added to Mining Stocks include: MANAGEM Group (Casablanca:MNG), Marathon Gold Corporation (TSX:MOZ.TO), Marlin Gold Mining Ltd. (TSX:MLN.V), Metals Creek Resources Corp. (TSX:MEK.V), MGX Minerals Inc. (CSE:XMG), Midas Gold Corp. (TSX:MAX.TO), Minera Alamos Inc. (TSX:MAI.V), MMG Inc. (Hong Kong: 1208.HK; ASX:MMG.AX), Montan Mining Corp. (TSX:MNY.V), Morien Resources Corp. (TSX:MOX.V), Murchison Minerals Ltd. (CSE:MUR)

Other Sector Additions:
Agriculture Stocks:
Ceres, Inc. (NasdaqCM:CERE) is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for animal feed, sugar and other markets. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology to other companies and organizations.

About Investorideas.com - Big Ideas for Global Investors
InvestorIdeas.com is a digital news source and investor resource covering leading sectors including biotech and life sciences.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411



Monday, May 2, 2016

Q BioMed Inc (OTCQB: $QBIO) News: Mannin Research to Participate at ARVO 2016 Meeting

Q BioMed Inc (OTCQB: $QBIO) News: Mannin Research to Participate at ARVO 2016 Meeting



NEW YORK - May 2, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company announces that its technology partner Mannin Research Inc. will be attending the Association for Research in Vision and Ophthalmology (ARVO), which takes place from May 1-5, 2016 in Seattle Washington. Mannin Research executives will be meeting with its vendors and research partners. The meeting provides organizations the opportunity to further explore business development goals and other collaborative opportunities for the MAN-01 program for treatment of glaucoma.

The ARVO annual meeting is the largest gathering of eye and vision researchers in the world. The annual meeting runs from May 1st to 5th at the Washing State Convention Center in Seattle, Washington, attracting over 11,000 attendees from more than 75 countries.

Mannin's CEO, Dr. George N. Nikopoulos stated: "We are very pleased to be attending the meeting. We are looking forward to engaging in meaningful research discussions and exploring possible collaboration opportunities with other innovative groups in attendance."

In October 2015 Q BioMed Inc entered into an agreement with Mannin Research to exclusively license, with an option to acquire, the platform technology assets of Mannin Research, the developer of a new class of vascular therapeutics. Mannin's primary focus is developing a first-in-class therapeutic eye-drop for glaucoma in adults and children, using a research platform designed to help develop new drugs for that indication and cystic kidney disease, among other diseases. Lead drug candidate MAN-01 is designed to treat abnormal vessels within the eye-thus treating glaucoma at its root causes.

We invite our shareholders and interested parties to subscribe to our email list and stay informed on our website at http://www.qbiomed.com and follow us on the social media feeds we use.


About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.

Forward-Looking Statements:
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435 

Visit this Company: http://www.qbiomed.com

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.








Friday, April 29, 2016

#Investorideas Updates Global #Stock Directories; Additions Include #Biotech & #LifeSciences Stocks

#Investorideas Updates Global #Stock Directories; Additions Include #Biotech & #LifeSciences Stocks

(OTC:ENVD), (OTC:IMUN), (OTC:MDIT), (OCT:NAOV), (OTC:RXMD) and (OTC:PRGB) Added

Point Roberts, WA, Delta BC – April 29, 2016 – Investorideas.com, a global news source and investor resource covering leading sectors announces this week’s additions to its global stock directories include biotech & life sciences stocks.

Companies added include: Endonovo Therapeutics, Inc. (OTC: ENDV), Immune Therapeutics, Inc. (OTC: IMUN), Medite Cancer Diagnostics, Inc. (OTC: MDIT), NanoVibronix Inc. (OTC: NAOV), Progressive Care, Inc. (OTC: RXMD) and Protea Biosciences Group, Inc. (OTC: PRGB).

The newly added companies were participants in the recent SeeThru Equity & Brewer Group 2ndAnnual Innovations and Investor Conference held this past February.


About Investorideas.com - Big Ideas for Global Investors
InvestorIdeas.com is a digital news source and investor resource covering leading sectors including biotech and life sciences.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411

Thursday, April 28, 2016

Q BioMed Inc (OTCQB: $QBIO) CEO Pens Management Piece Featured in Life Science Leader

Q BioMed Inc (OTCQB: $QBIO) CEO Pens Management Piece Featured in Life Science Leader


NEW YORK - April 28, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company reports the Company's CEO was featured in an article he wrote on venture capital titled Accelerators Enter When VCs Fear To Tread:

Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Their content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses.

Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharma and biopharma markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes.

Corin explains how times have changed for start-up biotechnology companies, though, and the challenges have grown in magnitude. These days, the very same venture capital firms that would hand out a few dollars in the early stages now are idling their time, investing much bigger sums only after much more development has occurred.

In the article, Corin leverages his expertise at Q BioMed Inc., where he focuses on acquiring licenses to innovative biomedical assets in the private company space or academic setting.
"Our team at Q Bio are dedicated to providing those developers with the strategic resources, developmental support, and expansion capital to ensure they meet their potential, with the ultimate goal of enabling them to provide products to patients in need. Our mission is to license and acquire innovative life sciences assets and accelerate their product development timelines to commercialize their drug candidates and devices or bring them to the next level in terms of valuation inflection and the attention of the larger Pharma players or IPO them as stand-alone companies or just grow a revenue model organically", states Corin.

Excerpt from the article:
"Most venture funds, for example, have become increasingly impatient to harvest returns from their investments, many expecting an 'exit' within only 2-4 years. This trend has been adverse for many biomedical technologies, since they generally have a much longer gestation cycle than communications, electronics or information technologies. In addition, many biomedical technologies require regulatory approvals, which further increases development costs and lengthens the investment cycle."

The one thing that really has not changed is the amount of equity the venture capitalists want when they finally do invest. For those who are only interested in getting their idea into the marketplace, giving up 80 or 90% of their company may be acceptable. Jonas Salk refused to patent his polio vaccine because his focus was preventing that disease and not making billions for himself. Handing off the headaches of running a business to people who studied accounting and marketing rather than organic chemistry and electrical engineering may be the solution for many researchers.

To read the entire article, please follow this link

About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.


Forward-Looking Statements:
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435 

Visit this Company: http://www.qbiomed.com

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.






Tuesday, April 26, 2016

Q BioMed Inc (OTCQB: $QBIO) to Present at the Global Chinese Financial Forum on April 30, 2016

Toronto, ON Conference Expects to Attract Over 200 Participants



NEW YORK - April 26, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company, today announced that the company will present at the Global Chinese Financial Forum (GCFF). The GCFF is the most prominent series of bi-lingual financial functions in both North America and China. Established in 2000, GCFF's mandate is to provide a world-class platform connecting both the Asian and North American financial markets. GCFF assembles companies, financial institutions and investors who are interested in exploring new investment ideas and financial opportunities.

The conference is being held at the Marriott Courtyard Hotel in Markham, Ontario Canada at 7095 Woodbine Ave, Markham, Ontario.

The conference runs from 9am to 5pm. Q BioMed CEO, Denis Corin, will present at 10:20am.

Organizers expect the conference to attract over 200 participants consisting of pre-qualified investors, industry executives and professional service providers.

For more information or to register as an attendee of the conference, please click HERE.

To stay informed on Q BioMed developments please visit our website http://www.qbiomed.com and sign up for our news distribution.


About GCFF - GLOBAL CHINESE FINANCIAL FORUM
Organized by NAI Interactive, the Global Chinese Financial Forum (GCFF) is the most prominent series of bi-lingual financial functions in both North America and China. Established in 2000, GCFF's mandate is to provide a world-class platform connecting both the Asian and North American financial markets. We assemble companies, financial institutions and investors who are interested in exploring new investment ideas and financial opportunities.

With an extensive network covering both the North American and Chinese market alongside expertise in the global capital market, GCFF is supported by a strong foundation of financial resources. It enables GCFF to organize resourceful financial events that facilitate business growth and networks among financial institutions, public corporations, private companies, and investors of all levels.

In the past 16 years, over 35 GCFF conferences have been held in multiple locations worldwide including Vancouver, Toronto and China. The latest LNG Investment Conference was held in April 2014 to enlighten the Chinese community on the latest LNG development in British Columbia. The conference attracted over 200 participants consisting of pre-qualified investors, industry executives and professional service providers.

About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.

Forward-Looking Statements:
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435 

Visit this Company: http://www.qbiomed.com

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.